tiprankstipranks
Pacira (PCRX)
:PCRX
US Market

Pacira Pharmaceuticals (PCRX) Income Statement

Compare
364 Followers

Pacira Pharmaceuticals Income Statement

Last quarter (Q4 2024), Pacira Pharmaceuticals's total revenue was $187.25M, an increase of 3.32% from the same quarter last year. In Q4, Pacira Pharmaceuticals's net income was $16.04M. See Pacira Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 700.97M$ 674.98M$ 666.82M$ 541.53M$ 420.83M
Gross Profit
$ 700.97M$ 490.31M$ 467.53M$ 401.28M$ 303.50M
Operating Expenses
$ 774.34M$ 402.63M$ 396.60M$ 268.44M$ 260.80M
Depreciation and Amortization
$ 78.78M$ 75.57M$ 91.50M$ 28.55M$ 19.91M
EBITDA
$ 29.12M$ 157.58M$ 144.78M$ 118.47M$ 71.42M
Operating Income
$ -73.37M$ 87.67M$ 60.02M$ 131.06M$ 46.35M
Other Income/Expenses
$ 10.27M$ -25.97M$ -46.72M$ -33.52M$ -26.26M
Pretax Income
$ -63.11M$ 61.70M$ 13.30M$ 56.40M$ 20.09M
Net Income
$ -99.56M$ 41.95M$ 15.91M$ 41.98M$ 145.52M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -2.15$ 0.91$ 0.35$ 0.95$ 3.41
Diluted EPS
$ -2.15$ 0.81$ 0.34$ 0.92$ 3.33
Weighted Average Shares Outstanding
46.24M 46.22M 45.52M 44.26M 42.67M
Weighted Average Shares Outstanding (Diluted)
46.24M 51.98M 46.54M 45.63M 43.68M
Currency in USD

Pacira Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis